Usage of Hemopoietic Precursor Cells for Correcting Immune-Physiological Disorders Under Dangerous and Critical States
Keywords:
cell therapy, immune correction, dangerous and critical statesAbstract
This research shows the usage of hemopoietic stem cells (HSCs) of fetal liver and cord blood hemopoietic precursor cells (CB HPCs) for correcting immunological disorders in patients with hepatocirrhosis, pancreas necrosis, diabetes of II type, Larish syndrome, polytrauma. The disorders in cell and humoral links of immune response have been revealed in the examined patients at their entering in the hospital. The HSCs and CB HPCs transfusions in the most of patients resulted in the positive changes of circulating immune complexes (CICs) concentration, CICs constant values, lymphotoxicity, level of CD3+, CD4+, CD8+ differentiated markers.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 E. M. Klimova, L. A. Drozdova, L. A. Shakina, T. S. Antonenko, O. S. Merezhko
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).